Is Jyong Biotech Ltd. (MENS) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2024
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 11.0% / 30% | 0.1% / 30% | 0.0% / 30% | N/A | ✓ HALAL |
| DJIM | 11.0% / 33% | 0.1% / 33% | 0.0% / 33% | N/A | ✓ HALAL |
| MSCI | 284.9% / 33% | 1.5% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 11.0% / 33% | 0.1% / 33% | 0.0% / 33% | N/A | ✓ HALAL |
| FTSE | 284.9% / 33% | 1.5% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Assets (ROA) | -5.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$4M |
| Free Cash Flow | -$4M |
| Total Debt | $18M |
| Current Ratio | 0.6 |
| Total Assets | $6M |
Price & Trading
| Last Close | $2.02 |
| 50-Day MA | $2.24 |
| 200-Day MA | $24.42 |
| Avg Volume | 477K |
|
52-Week Range
$1.43
| |
About Jyong Biotech Ltd. (MENS)
Jyong Biotech Ltd., a science-driven biotechnology company, develops and commercializes plant-derived drugs for the treatment of urinary system diseases in the United States, the European Union, and Asia. It develops MCS-2 for the treatment of benign prostate hyperplasia/lower urinary tract symptoms; PCP for treating prostate cancer; and interstitial cystitis (IC) for the treatment of IC/bladder pain syndrome. The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Jyong Biotech Ltd. (MENS) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Jyong Biotech Ltd. is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Jyong Biotech Ltd.'s debt ratio?
Jyong Biotech Ltd.'s debt ratio is 11.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 284.9%.
What are Jyong Biotech Ltd.'s key financial metrics?
Jyong Biotech Ltd. has a market capitalization of $147M.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.